Accure Acne
Accure Acne is a Boulder, Colorado-based medical device company that sells the FDA-cleared Accure Acne Laser System — a 1726 nm laser with proprietary treat-to-temperature technology — exclusively to board-certified dermatologists for treating inflammatory acne vulgaris.
- Company typePrivate
- Founded2016
- HeadquartersBoulder, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Accure Acne does
Accure Acne, Inc. is a privately held, US-based medical device company founded in 2016 and headquartered in Boulder, Colorado. It develops and commercializes the Accure Acne Laser System, a single-platform, FDA-cleared (510(k), November 2022) and CE-Marked energy-based device that uses a 1726 nm wavelength laser paired with a proprietary treat-to-temperature algorithm, a thermal imaging camera, and a forced-air cooling system to selectively target overactive sebaceous glands — a root cause of inflammatory acne — while sparing surrounding tissue. Clinical data cited by the company shows average 70% lesion reduction at six months after four monthly sessions, 95% patient satisfaction in boost mode, and durability up to 33 months across Fitzpatrick skin types.
The company serves two interlocking customer segments: (i) acne patients age 16+ across all skin types who seek a non-systemic alternative to isotretinoin or antibiotics, and (ii) board-certified dermatologists and dermatology practices that purchase the capital equipment and deliver the four-session treatment protocol in-office. Its go-to-market is exclusively direct enterprise sales to dermatologists — supported by a Provider Portal, dedicated sales contact flows, and patient-facing marketing (social media, website quiz, provider locator) — with an additional federal channel via a March 2024 distribution partnership with MellingMedical to reach VA hospitals and military medical centers. Revenue is generated through one-time hardware sales of the laser system (quote-based, with LeasePoint financing available) plus downstream treatment-session economics realized by the practice.
The leadership team includes founder/CEO Christopher Carlton (prior CEO of Quanta Aesthetic Lasers USA and former President NA at Syneron-Candela), CFO Karl Nicholls, CTO Alfred Intintoli (joined April 2023), CCO Vladimir Paul-Blanc, and Chief Scientific & Medical Officer Dr. Rox Anderson, co-founder and inventor of selective cryolipolysis (the basis for Zeltiq, acquired by Allergan for ~$2.4B). Accure has raised a disclosed $20M in April 2021, holds a global IP portfolio, and has built an advisory network of leading academic dermatologists from Harvard, Scripps, NYU, and international institutions.
Accure Acne firmographics
Firmographics- Name
- Accure Acne
- Legal name
- Accure Acne, Inc.
- Website
- https://accureacne.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Accure Acne is a Boulder, Colorado-based medical device company that sells the FDA-cleared Accure Acne Laser System — a 1726 nm laser with proprietary treat-to-temperature technology — exclusively to board-certified dermatologists for treating inflammatory acne vulgaris.
- Ownership category
- akta.pro rank
Accure Acne industry classification
Industry- Product category
- Medical Aesthetic Laser Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Laser & Energy-Based Dermatology (HLAKACAF)
Keywords
Where Accure Acne is headquartered
LocationHeadquarters
- HQ city
- Boulder
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Accure Acne business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain, Infrastructure
Revenue model
- Laser System Hardware Sales: Sale of the Accure Acne Laser System to dermatologists and dermatology practices. The device is sold as capital equipment to providers who then offer treatments to patients.
- Treatment Sessions: Dermatologists perform four treatment sessions spaced one month apart. Revenue is generated at the practice level through patient payments for laser treatments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Laser System - Quote-based pricing for dermatology practices |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Accure Acne product offering
Product offeringCore offering
Accure Acne develops, manufactures, and sells the FDA-cleared Accure Acne Laser System, a 1726 nm medical laser device with proprietary treat-to-temperature technology designed to selectively target overactive sebaceous glands for the treatment of mild to severe inflammatory acne vulgaris on the face and body. The system is sold as capital equipment exclusively to board-certified dermatologists, who administer four treatment sessions spaced one month apart in their offices. The company supports its device with a Provider Portal, clinical training, and a Find-a-Provider locator that connects patients to certified practices.
Product overview
Accure Acne offers a single unified product—the Accure Acne Laser System. This is a medical laser device featuring a proprietary 1726 nm wavelength with a treat-to-temperature algorithm and forced-air cooling system. The treatment consists of four sessions spaced one month apart, performed exclusively in dermatologists' offices. The system targets overactive sebaceous glands (a root cause of acne) while preserving surrounding healthy skin.
Differentiator
Problem solved
Functional benefit
Brands
- AcneTech™: Technology platform and approach used in the Accure Acne Laser System
Products and services
- Accure Acne Laser System FDA-cleared medical laser device using a proprietary 1726 nm wavelength combined with a treat-to-temperature algorithm, real-time thermal imaging, and forced-air cooling to selectively target overactive sebaceous glands for the treatment of mild to severe inflammatory acne vulgaris on the face and body. Sold as capital equipment exclusively to board-certified dermatologists, who administer four treatment sessions spaced one month apart. CE Mark approved for international commercialization.
Quantifiable outcome
- 95% of patients very or extremely satisfied with Accure treatment (boost mode)
- +4 more outcomes
Companies that use Accure Acne
Customer profileNamed customers7 records
Segments2 records
Ideal customer profiles3 records
Accure Acne technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Accure Acne partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MellingMedicalcoreMellingMedical announced a new distribution relationship with Accure Acne to deliver the groundbreaking Accure Acne Laser to federal health facilities. This partnership enables Accure to reach government healthcare settings including VA hospitals and military medical centers, expanding beyond private dermatology practices.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Accure Acne competitors and assessment
Company assessmentDirect peers
- Cynosure (Hologic): Cynosure sells aesthetic laser and energy-based device platforms into dermatology and med-spa channels; former Accure advisor Rafael Sierra was CTO of Cynosure, underscoring direct competitive overlap.
- Cutera: Cutera markets laser and energy-based aesthetic systems (excel V, AviClear for acne) sold to dermatologists and med-spas — directly comparable capital-equipment model and customer segment to Accure.
- Solta Medical (Bausch Health): Solta markets energy-based aesthetic devices (Thermage, Fraxel, Clear+Brilliant) sold through dermatologists and plastic surgeons — same customer base, similar capital-equipment GTM as Accure.
- Sciton: Sciton manufactures aesthetic and medical laser platforms (BBL, Halo, Joule) sold into dermatology practices — same channel, same laser-device category as Accure.
- Quanta System: Quanta System is an Italian aesthetic/medical laser manufacturer whose US arm was previously led by Accure CEO Christopher Carlton — a near-direct product and channel comparable.
- Alma Lasers: Alma is a global aesthetic and surgical laser device vendor (Accent, Soprano) competing for the same dermatologist purchasing budget as Accure.
Emerging players
- Aerolase: Aerolase produces portable aesthetic and medical lasers (Neo) used by dermatologists for acne and skin conditions; smaller scale than the incumbents but a direct emerging competitor in laser acne treatment.
- Avava: Avava is an emerging aesthetics-focused laser company targeting dermatology practices; positioned as a smaller, niche player similar in stage to Accure.
Broad incumbents
- Lumenis (Boston Scientific): Lumenis is a large, diversified surgical and aesthetic laser vendor whose energy-based platforms overlap with Accure's dermatologist-channel capital equipment sales.
- InMode: InMode markets a broad portfolio of aesthetic and wellness devices (Morpheus8, Evolve) into dermatology and plastic surgery practices — overlapping customer base with Accure.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Accure Acne social profiles
Digital presenceAccure Acne compliance and trust
Trust signalCompliance2 records
Accure Acne financial estimates
Financial estimateRevenue estimate
Valuation estimate
Accure Acne leadership team
Management profileNumber of profiles
Profiles8 records
Accure Acne funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Accure Acne M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Accure Acne
What does Accure Acne do?
Accure Acne develops, manufactures, and sells the FDA-cleared Accure Acne Laser System, a 1726 nm medical laser device with proprietary treat-to-temperature technology designed to selectively target overactive sebaceous glands for the treatment of mild to severe inflammatory acne vulgaris on the face and body. The system is sold as capital equipment exclusively to board-certified dermatologists, who administer four treatment sessions spaced one month apart in their offices. The company supports its device with a Provider Portal, clinical training, and a Find-a-Provider locator that connects patients to certified practices.
Is Accure Acne a public or private company?
Accure Acne is a private company. It is classified as venture growth investor backed and is currently operating.
When was Accure Acne founded?
Accure Acne was founded in 2016. It employs 11 to 50 people.
Where is Accure Acne based?
Accure Acne is headquartered in Boulder, United States, in the North America region.
How does Accure Acne make money?
Two revenue lines are on record. Laser System Hardware Sales are the primary driver. The others are treatment Sessions.
Who are Accure Acne's main competitors?
Direct peers on record are Cynosure (Hologic), Cutera, Solta Medical (Bausch Health), Sciton, Quanta System and Alma Lasers. Emerging players are Aerolase and Avava. Broad incumbents are Lumenis (Boston Scientific) and InMode.
Does Accure Acne have an API?
No public API is recorded for Accure Acne.
What industry is Accure Acne in?
Accure Acne's product category is Medical Aesthetic Laser Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology. Its NAICS code is 334510 and its SIC code is 3845.